LabGenomics Co., Ltd. (KOSDAQ: A084650)
Health Care · Biotechnology · KR
₩2,440.00
-12.07% today · -78.3% 1Y
LabGenomics Co., Ltd. (KOSDAQ: A084650) operates in the Biotechnology industry within the Health Care sector. The company is valued at $27.17M.
Over the last twelve months the share price has lost 78.3%, trading between 2.26K and 12.72K.
Tweenvest scores LabGenomics Co., Ltd. across four factors: quality 60/100, value 72/100, growth 0/100. Its strongest factor is value.
A084650 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.17M
- Revenue (TTM)
- $50.14M
- P/E
- —
- EPS
- -3,770.08
- Dividend yield
- —
- Beta (5Y)
- 0.14
- 52-week high
- ₩12,725.00
- 52-week low
- ₩2,260.00
- Avg volume (3M)
- —
- Shares outstanding
- 14.85M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zenotech Laboratories LimitedBSE: 532039 | $27.69M | Rs43.06 | -0.02% |
| Kohjin Bio Co., Ltd.TSE: 177A | $27.45M | ¥848.00 | +4.05% |
| Chordia Therapeutics Inc.TSE: 190A | $27.40M | ¥56.00 | -1.75% |
| IMB Dx, Inc.KOSDAQ: A461030 | $27.39M | ₩2,605.00 | -8.44% |
| Isofol Medical AB (publ)OM: ISOFOL | $26.73M | Skr0.83 | +3.51% |
| Kim Forest Enterprise Co., Ltd.TWSE: 6645 | $26.71M | NT$14.35 | +6.30% |
| Atossa Therapeutics, Inc.NasdaqCM: ATOS | $25.95M | $2.60 | -4.41% |
| Noile-Immune Biotech Inc.TSE: 4893 | $25.84M | ¥94.00 | -7.84% |
Figures last refreshed Oct 18, 2026.